Study flow chart. by Raymond Atwine (18574812)

Subjects:

Bar graph showing proportion of NADCs. by Raymond Atwine (18574812)

Subjects:

Line graph showing the trends of ADCs and NADCS over the 10 years period. by Raymond Atwine (18574812)

Subjects:

Outcome comparisons of study participant characteristics. by Raymond Atwine (18574812)

Subjects:

Baseline characteristics of study participants. by Raymond Atwine (18574812)

Subjects:

Effect of the different variables on ADCs in univariate and multivariate analysis. by Raymond Atwine (18574812)

Subjects:

Line graph showing the trends of ADCs and NADCs with CD4 counts. by Raymond Atwine (18574812)

Subjects:

Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

“…</p><p>Conclusions</p><p>Clinicians should assess and address patients’ recovery expectations early in the care process, as these may significantly influence long-term HRQoL outcomes. Incorporating strategies to support realistic yet positive expectations, such as cognitive-behavioral therapy, structured patient education, and goal-setting programs, may improve recovery experiences. …”

Table 1_Significance of host antimicrobial peptides in the pathogenesis and treatment of acne vulgaris.docx by Agata Lesiak (17951854)

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... by Nattapon Riengvirodkij (11268720)

Subjects:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient of all 17 dogs. by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Experimental process. by Yi Wang (32470)

Subjects:

SARA test results for different types of asphalt. by Yi Wang (32470)

Subjects:

SARA test results of different asphalt. by Yi Wang (32470)

Subjects:

Different asphalt modeling. by Yi Wang (32470)

Subjects: